The Mechanism of Ethoxydihydrosanguinarine Targeting EGFR to Inhibit Malignant
 Progression and Induce Apoptosis of Colorectal Cancer

doi:10.3870/j.issn.1672-0741.23.06.008

Acta Medicinae Universitatis Scientiae et Technologiae Huazhong ›› 2024, Vol. 53 ›› Issue (3): 328-337.doi: 10.3870/j.issn.1672-0741.23.06.008

Previous Articles Next Articles

The Mechanism of Ethoxydihydrosanguinarine Targeting EGFR to Inhibit Malignant Progression and Induce Apoptosis of Colorectal Cancer

Received:2023-06-01 Online:2024-06-15 Published:2024-06-21

Abstract

CLC Number:

R735.3

Tan Miao, Qian Chen, Xiang Ke, et al. The Mechanism of Ethoxydihydrosanguinarine Targeting EGFR to Inhibit Malignant Progression and Induce Apoptosis of Colorectal Cancer[J]. Acta Medicinae Universitatis Scientiae et Technologiae Huazhong, 2024, 53(3): 328-337.

[1]	Liao Weiwei, Fu Xiangwei, Wen Bisheng, et al. Influences of lncRNACASC11 on Proliferation and Invasion of Colon Cancer Cells by Targeting miR-146a-3p [J]. Acta Medicinae Universitatis Scientiae et Technologiae Huazhong, 2023, 52(6): 803-809.
[2]	. [J]. Acta Medicinae Universitatis Scientiae et Technologiae Huazhong, 2022, 51(3): 303-308.
[3]	. [J]. Acta Medicinae Universitatis Scientiae et Technologiae Huazhong, 2022, 51(3): 354-359.

The Mechanism of Ethoxydihydrosanguinarine Targeting EGFR to Inhibit Malignant Progression and Induce Apoptosis of Colorectal Cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 3

Recommended Articles

Metrics

Comments